tiprankstipranks
Orthocell Ltd (AU:OCC)
ASX:OCC
Australian Market

Orthocell Ltd (OCC) Share Price & Analysis

2 Followers

OCC Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.32 - AU$0.46
Previous CloseAU$0.41
Volume210.00
Average Volume (3M)145.39K
Market Cap
AU$80.70M
Enterprise ValueAU$70.19M
Total Cash (Recent Filing)AU$11.02M
Total Debt (Recent Filing)AU$507.56K
Price to Earnings (P/E)-12.8
Beta1.07
Feb 27, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding199,267,357
10 Day Avg. Volume951,707
30 Day Avg. Volume145,388
Standard Deviation0.42
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
Price Target Upside224.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1


Financials

Annual

Ownership Overview

0.00% Mutual Funds
0.00% Other Institutional Investors
91.25% Public Companies and
Individual Investors

OCC FAQ

What was Orthocell Ltd’s price range in the past 12 months?
Orthocell Ltd lowest share price was AU$0.32 and its highest was AU$0.46 in the past 12 months.
    What is Orthocell Ltd’s market cap?
    Currently, no data Available
    When is Orthocell Ltd’s upcoming earnings report date?
    Orthocell Ltd’s upcoming earnings report date is Feb 27, 2024 which is in 81 days.
      How were Orthocell Ltd’s earnings last quarter?
      Orthocell Ltd released its earnings results on Aug 31, 2023. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
        Is Orthocell Ltd overvalued?
        According to Wall Street analysts Orthocell Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Orthocell Ltd pay dividends?
          Orthocell Ltd does not currently pay dividends.
          What is Orthocell Ltd’s EPS estimate?
          Orthocell Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Orthocell Ltd have?
          Orthocell Ltd has 199,267,360 shares outstanding.
            What happened to Orthocell Ltd’s price movement after its last earnings report?
            Orthocell Ltd reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Orthocell Ltd?
              Currently, no hedge funds are holding shares in AU:OCC

              ---

              Company Description

              Orthocell Ltd

              Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cell therapies and related technologies. Its product includes CelGro is a naturally derived collagen medical device for tissue repair and Ortho-ATI is a first-in-class cell therapy for the treatment of chronic tendon injuries.

              ---

              Forecast EPS vs Actual EPS


              Similar Stocks
              Company
              Price & Change
              Follow
              Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
              Integral Diagnostics Ltd.
              PainChek Ltd
              MedAdvisor Limited

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis